Biotech Holdings is a pharmaceutical production and distribution company based in Vancouver, Canada.

Biotech has developed an important new anti-diabetic medication, which has been trademarked as "Sucanon" and "Diab II". Biotech is now focused on the distribution and marketing of this medication. The Company also looks forward to development of combination therapies using this new proprietary medication in combination with other well-established treatments for Type II Diabetes, which is one of the world's most widespread and rapidly growing diseases.